Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.21.1
Equity (Details) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Dec. 29, 2020
Stockholders' Equity (Details) [Line Items]      
Costs Incurred $ 800,000    
Warrants and Rights Outstanding $ 518,847,000    
Common Stock, Shares, Outstanding 85,339,145 84,535,640  
Outstanding warrants (in Shares)   10,000,000 55,139
Warrant price per share $ 11.50 $ 30  
Shares, Issued 208,183    
Weighted Average Exercise Price of per share (in Dollars per share) $ 30    
Exercisable and remained outstanding shares (in Dollars) $ 15,744,316    
Exercisable and remained outstanding ( in shares) 30,493    
Conversion of Stock, Shares Converted 279,253 506,611  
Class of Warrant or Right, Outstanding   10,000,000 55,139
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 11.50 $ 30  
Conversion of Stock, Shares Issued 435,961    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value $ 18.52    
Weighted Average Exercise Price, Exercised (in Dollars per share) 3.28 $ 3.28  
Public Warrants      
Stockholders' Equity (Details) [Line Items]      
Price per share $ 18.00    
Warrants and Rights Outstanding $ 518,847,000    
Outstanding warrants (in Shares) 5,481,153 6,000,000  
Warrant price per share $ 11.50    
Redeemable outstanding warrants price $ 0.01    
Class of Warrant or Right, Outstanding 5,481,153 6,000,000  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 11.50